Bill Details - SB581 (2018)

CHAPTER 263

SB 581-FN - FINAL VERSION

 

03/14/2018   0976s

2May2018... 1718h

2018 SESSION

18-2755

01/03

 

SENATE BILL 581-FN

 

AN ACT relative to compounding of drugs and establishing a committee to study rulemaking authority for reconstituted drugs.

 

SPONSORS: Sen. Sanborn, Dist 9

 

COMMITTEE: Health and Human Services

 

─────────────────────────────────────────────────────────────────

 

AMENDED ANALYSIS

 

This bill amends the definition of compounding for the purposes of the law regulating pharmacists and pharmacies.  This bill also establishes a study committee to study rulemaking authority for reconstituted drugs.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/14/2018   0976s

2May2018... 1718h 18-2755

01/03

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Eighteen

 

AN ACT relative to compounding of drugs and establishing a committee to study rulemaking authority for reconstituted drugs.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

263:1  Pharmacists and Pharmacies; Definitions.  Amend RSA 318:1, III-a to read as follows:

III-a.  "Compounding'' means the preparation, mixing, assembling, packaging or labeling of a drug or device as a result of a practitioner's prescription drug order or initiative based on the pharmacist-patient-prescriber relationship in the course of professional practice or, for the purpose of, or as an incident, to research, teaching, or chemical analysis, but not selling or dispensing.  "Compounding'' also includes the preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns.  "Compounding'' shall not include the reconstitution of powdered formulations before dispensing or the addition of flavoring.  "Compounding" shall not include the simple addition of flavoring, nor shall it include the preparation of a single dose of a nonhazardous commercially available drug or licensed biologic for administration within 2 hours of preparation to an individual patient when done in accordance with the manufacturer's approved labeling or instructions consistent with that labeling.

263:2  Committee Established.  There is established a committee to study rulemaking authority for reconstituted drugs.

263:3  Membership and Compensation.

I.  The members of the committee shall be as follows:

(a)  Three members of the house of representatives, at least 2 of whom shall be from the house executive departments and administration committee, appointed by the speaker of the house of representatives.

(b)  One member of the senate, appointed by the president of the senate.

II.  Members of the committee shall receive mileage at the legislative rate when attending to the duties of the committee.

263:4  Duties.  The committee shall study rulemaking authority for reconstituted drugs.  The committee shall solicit information and testimony from any individual or entity the committee deems relevant to its study.

263:5  Chairperson; Quorum.  The members of the study committee shall elect a chairperson from among the members.  The first meeting of the committee shall be called by the first-named house member.  The first meeting of the committee shall be held within 45 days of the effective date of this section.  Three members of the committee shall constitute a quorum.

263:6  Report.  The committee shall report its findings and any recommendations for proposed legislation to the speaker of the house of representatives, the president of the senate, the house clerk, the senate clerk, the governor, and the state library on or before November 1, 2018.

263:7  Effective Date.  This act shall take effect upon its passage.

 

Approved: June 12, 2018

Effective Date: June 12, 2018

 

 

Docket

Date Status
Jan. 3, 2018 Introduced 01/03/2018 and Referred to Health and Human Services; SJ 2
Jan. 23, 2018 Hearing: 01/23/2018, Room 101, LOB, 01:30 pm; SC 4
March 8, 2018 Committee Report: Ought to Pass with Amendment # 2018-0976s, 03/08/2018; Vote 5-0; CC; SC 10A
March 8, 2018 Sen. Bradley Moved to Remove SB 581 from the Consent Calendar; 03/08/2018; SJ 6
March 8, 2018 Special Order to the next session, Without Objection, MA; 03/08/2018; SJ 6
March 14, 2018 Committee Report: Ought to Pass with Amendment # 2018-0976s, 03/14/2018; SC 11
March 14, 2018 Committee Amendment # 2018-0976s, AA, VV; 03/14/2018; SJ 7
March 14, 2018 Ought to Pass with Amendment 2018-0976s, MA, VV; OT3rdg; 03/14/2018; SJ 7
March 14, 2018 Without Objection, the Clerk is authorized to make technical and adminsitrative corrections which are necessary to reflect the intent of the Senate, MA; 03/14/2018; SJ 7
March 15, 2018 Introduced 03/15/2018 and referred to Executive Departments and Administration
Please note: The Clerk was instructed to correct the amended analysis; SJ 7
March 15, 2018 Introduced 03/15/2018 and referred to Executive Departments and Administration HJ 8 P. 71
April 11, 2018 Public Hearing: 04/11/2018 10:00 AM LOB 306
April 17, 2018 Subcommittee Work Session: 04/17/2018 02:00 PM LOB 308
April 24, 2018 ==ROOM CHANGE== Subcommittee Work Session: 04/24/2018 12:50 PM LOB 307
April 24, 2018 Executive Session: 04/24/2018 LOB 306
Committee Report: Ought to Pass with Amendment # 2018-1718h (NT) (Vote 17-1; CC)
May 2, 2018 Committee Report: Ought to Pass with Amendment # 2018-1718h (NT) for 05/02/2018 (Vote 17-1; CC) HC 17 P. 6
May 2, 2018 Amendment # 2018-1718h: AA VV 05/02/2018
May 2, 2018 Ought to Pass with Amendment 1718h: MA VV 05/02/2018
May 10, 2018 Sen. Bradley Moved to Concur with the House Amendment, MA, VV; 05/10/2018; SJ 17
May 23, 2018 Enrolled 05/23/2018
May 23, 2018 Enrolled (In recess 05/23/2018); SJ 18
June 12, 2018 Signed by the Governor on 06/12/2018; Chapter 0263; Effective 06/12/2018

Action Dates

Date Body Type
Jan. 23, 2018 Senate Hearing
March 8, 2018 Senate Floor Vote
March 8, 2018 Senate Floor Vote
March 14, 2018 Senate Floor Vote
April 11, 2018 House Hearing
April 24, 2018 House Exec Session
House Floor Vote
May 2, 2018 House Floor Vote

Bill Text Revisions

SB581 Revision: 2960 Date: Jan. 17, 2018, 8:47 a.m.
SB581 Revision: 3267 Date: March 14, 2018, 5:13 p.m.
SB581 Revision: 3668 Date: May 2, 2018, 1:24 p.m.
SB581 Revision: 3868 Date: May 11, 2018, 9:33 a.m.
SB581 Revision: 4181 Date: June 16, 2018, 9 a.m.
SB581 Revision: 4183 Date: June 18, 2018, 8 a.m.